Cite
HARVARD Citation
Sengal, A. et al. (n.d.). P87 Mesenchymal splice isoform fibroblast growth factor receptor (FGFR2c) is an independent prognostic biomarker and further refines risk stratification within endometrial cancer molecular subtypes. International journal of gynecological cancer. p. A107. [Online].